Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Lafourcade

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
RMD Open|May 9, 2022
Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohortJoanna Kedra, Alexandre Lafourcade, Bernard Combe, et al.
Biometrical Journal. Biometrische Zeitschrift|September 27, 2018
Closed-form variance estimator for weighted propensity score estimators with survival outcomeDavid Hajage, Guillaume Chauvet, Lisa Belin, et al.
BMC Cancer|February 11, 2018
Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohortAlexandre Lafourcade, Mathilde His, Laura Baglietto, et al.
Pharmacoepidemiology and Drug Safety|June 26, 2019
Impact of a population-based asthma management program in France (Sophia Asthme): A matched controlled before-and-after quasi-experimental study using the French health insurance database (SNDS)Fadia Dib, Yann de Rycke, Sylvie Guillo, et al.
RMD Open|June 23, 2022
Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare databaseRaphaele Seror, Alexandre Lafourcade, Yann De Rycke, et al.
Rheumatology (Oxford, England)|May 26, 2018
Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohortBaptiste Louveau, Yann De Rycke, Alexandre Lafourcade, et al.
Surgery|August 29, 2024
Evaluating the impact and costs of conversional or revisional metabolic bariatric surgery on obstructive sleep apnea: Insights from a French nationwide cohortJérémie Thereaux, Mohammed Bennani, Jean Khemis, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|September 10, 2024
Effectiveness of conversional metabolic and bariatric surgery on dyslipidemia and the cost of lipid-lowering medications over 4 years: a French nationwide studyJérémie Thereaux, Mohammed Bennani, Jean Khemis, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 24, 2024
Cost-Effectiveness of Sleeve Gastrectomy and Gastric Bypass as Revisional Surgery on Antidiabetic Reimbursement: A Nationwide Cohort StudyJérémie Thereaux, Mohammed Bennani, Jean Khemis, et al.
Blood Pressure|December 23, 2014
Is home blood pressure monitoring feasible and well accepted in nephrectomized patients for renal cancer? (STAFF study)Nolwenn Lorcy, Caroline Dourmap-Collas, Alexandre Lafourcade, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
RMD Open|May 9, 2022
Positive impact on 10-year outcome of the window of opportunity for conventional synthetic DMARDs in rheumatoid arthritis: results from the ESPOIR cohortJoanna Kedra, Alexandre Lafourcade, Bernard Combe, et al.
Biometrical Journal. Biometrische Zeitschrift|September 27, 2018
Closed-form variance estimator for weighted propensity score estimators with survival outcomeDavid Hajage, Guillaume Chauvet, Lisa Belin, et al.
BMC Cancer|February 11, 2018
Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: the French E3N cohortAlexandre Lafourcade, Mathilde His, Laura Baglietto, et al.
Pharmacoepidemiology and Drug Safety|June 26, 2019
Impact of a population-based asthma management program in France (Sophia Asthme): A matched controlled before-and-after quasi-experimental study using the French health insurance database (SNDS)Fadia Dib, Yann de Rycke, Sylvie Guillo, et al.
RMD Open|June 23, 2022
Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare databaseRaphaele Seror, Alexandre Lafourcade, Yann De Rycke, et al.
Rheumatology (Oxford, England)|May 26, 2018
Effect of cumulative exposure to corticosteroid and DMARD on radiographic progression in rheumatoid arthritis: results from the ESPOIR cohortBaptiste Louveau, Yann De Rycke, Alexandre Lafourcade, et al.
Surgery|August 29, 2024
Evaluating the impact and costs of conversional or revisional metabolic bariatric surgery on obstructive sleep apnea: Insights from a French nationwide cohortJérémie Thereaux, Mohammed Bennani, Jean Khemis, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|September 10, 2024
Effectiveness of conversional metabolic and bariatric surgery on dyslipidemia and the cost of lipid-lowering medications over 4 years: a French nationwide studyJérémie Thereaux, Mohammed Bennani, Jean Khemis, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 24, 2024
Cost-Effectiveness of Sleeve Gastrectomy and Gastric Bypass as Revisional Surgery on Antidiabetic Reimbursement: A Nationwide Cohort StudyJérémie Thereaux, Mohammed Bennani, Jean Khemis, et al.
Blood Pressure|December 23, 2014
Is home blood pressure monitoring feasible and well accepted in nephrectomized patients for renal cancer? (STAFF study)Nolwenn Lorcy, Caroline Dourmap-Collas, Alexandre Lafourcade, et al.
Pageof 2